Clinical Trial Update: Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of OBT076 in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma of the Head and Neck

Drugs mentioned

• OBT076 (OBT076)

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Adenoid Cystic Carcinoma of the Head and Neck | Phase 1 | Status: TERMINATED